Level of omentin in chronic inflammatory rheumative diseases

Abstract

At the moment, a number of studies have been carried out that have proven that omentin has a sensitizing effect on insulin, has anti-inflammatory and anti-atherosclerotic effects. Plasma levels of omentin are known to be significantly reduced in obese patients with insulin resistance. Decreased levels of omentin have also been reported to be associated with inflammatory and autoimmune diseases, including atherosclerosis and psoriasis. The article presents research data that allow to identify changes in the level of omentin in chronic inflammatory rheumatic diseases, as well as to suggest its effect on the risk of development and course of cardiovascular complications.